


Oncolinx Email Formats
Biotechnology Research • United States • 1-10 Employees
Key Contact at Oncolinx
Doug Jensen
Director Board Of Directors
Company overview
| Headquarters | United States |
| Phone number | +442035141013 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Founded | 2013 |
| Employees | 1-10 |
| Socials |
About Oncolinx
Oncolinx is developing the next generation of antibody-drug conjugates (ADCs)--powerful, targeted cancer therapies that are more effective and have dramatically fewer side effects than current methods of cancer treatment. These therapies can be targeted to nearly any type of cancer and are rapidly becoming the state-of-the-art in cancer treatment. Drawing on the scientific innovation of the National Cancer Institute, the world's leading biotechs and life sciences companies, Oncolinx is redefining the paradigm of cancer therapy.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Oncolinx Tech Stack
Discover the technologies and tools that power Oncolinx's digital infrastructure, from frameworks to analytics platforms.
JavaScript frameworks
Blogs
JavaScript libraries
JavaScript frameworks
Frequently asked questions
4.8
40,000 users



